Rosemary Waring
(Former)
51 - 60 out of 81Page size: 10
Publications
- Published
A review of xenobiotic metabolising enzymes in Parkinson's disease and motor neurone disease
Rosemary Waring & Adrian Williams, 1 Jan 2001, In: Drug Metabolism and Drug Interactions. 18, p. 79-98 20 p.Research output: Contribution to journal › Article
- Published
Detection of endocrine disruptors - from simple assays to whole genome scanning.
Rosemary Waring & David Ramsden, 19 Mar 2012, In: International Journal of Andrology.Research output: Contribution to journal › Article
- Published
The effect of plasticisers on 'sulphate supply' enzymes
Rosemary Waring & David Ramsden, 1 Dec 2005, In: Molecular and Cellular Endocrinology. 244, 1-2, p. 15-19 5 p.Research output: Contribution to journal › Article
- Published
Wide-Ranging Genomic Effects of Plasticisers and Related Compounds
Nil Turan Jurdzinski, Rosemary Waring & David Ramsden, 1 May 2008, In: Current Drug Metabolism. 9, 4, p. 285-303 19 p.Research output: Contribution to journal › Article
- Published
Mushroom toxins
Rosemary Waring, Rosemary Waring, 1 Jan 2007, The molecules of death.Research output: Chapter in Book/Report/Conference proceeding › Chapter
- Published
Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man
Rosemary Waring, 1 Jan 2003, In: Drug Metabolism and Drug Interactions. 19, p. 241-255 15 p.Research output: Contribution to journal › Article
- Published
- Published
Endocrine disruptors - what are they and why is there so much interest?
Rosemary Waring, 1 Mar 2007, In: Chimica Oggi / Chemistry Today. 25, 2, p. 34-36 3 p.Research output: Contribution to journal › Article
- Published
Editorial [ Environmental Impacts on Enzymes Involved in Drug and Steroid Metabolism Guest Editor: R.H. Waring ]
Rosemary Waring, 1 May 2008, In: Current Drug Metabolism. 9, 4, p. 267-268 2 p.Research output: Contribution to journal › Editorial
- Published